AAAAAA

   
Results: 1-11 |
Results: 11
PHARMACOKINETICS OF RECOMBINANT HUMAN INTERFERON-ALPHA-2A COMBINED WITH 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
Authors: KIM J ZHI JG SATOH H KOSSTWARDY SG PASSE SM PATEL IH PAZDUR R
Citation: J. Kim et al., PHARMACOKINETICS OF RECOMBINANT HUMAN INTERFERON-ALPHA-2A COMBINED WITH 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Anti-cancer drugs, 9(8), 1998, pp. 689-696
THE EFFECT OF ORLISTAT, AN INHIBITOR OF DIETARY-FAT ABSORPTION, ON THE ABSORPTION OF VITAMIN-A AND VITAMIN-E IN HEALTHY-VOLUNTEERS
Authors: MELIA AT KOSSTWARDY SG ZHI JG
Citation: At. Melia et al., THE EFFECT OF ORLISTAT, AN INHIBITOR OF DIETARY-FAT ABSORPTION, ON THE ABSORPTION OF VITAMIN-A AND VITAMIN-E IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(7), 1996, pp. 647-653
THE EFFECT OF ORLISTAT ON THE PHARMACOKINETICS OF PHENYTOIN IN HEALTHY-VOLUNTEERS
Authors: MELIA AT MULLIGAN TE ZHI JG
Citation: At. Melia et al., THE EFFECT OF ORLISTAT ON THE PHARMACOKINETICS OF PHENYTOIN IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(7), 1996, pp. 654-658
THE EFFECT OF ORLISTAT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY-VOLUNTEERS
Authors: ZHI JG MELIA AT GUERCIOLINI R KOSSTWARDY SG PASSE SM RAKHIT A SADOWSKI JA
Citation: Jg. Zhi et al., THE EFFECT OF ORLISTAT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(7), 1996, pp. 659-666
THE EFFECT OF ORLISTAT, AN INHIBITOR OF DIETARY-FAT ABSORPTION, ON THE PHARMACOKINETICS OF BETA-CAROTENE IN HEALTHY-VOLUNTEERS
Authors: ZHI JG MELIA AT KOSSTWARDY SG ARORA S PATEL IH
Citation: Jg. Zhi et al., THE EFFECT OF ORLISTAT, AN INHIBITOR OF DIETARY-FAT ABSORPTION, ON THE PHARMACOKINETICS OF BETA-CAROTENE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(2), 1996, pp. 152-159
METABOLIC PROFILES OF MINIMALLY ABSORBED ORLISTAT IN OBESE OVERWEIGHTVOLUNTEERS/
Authors: ZHI JG MELIA AT FUNK C VIGERCHOUGNET A HOPFGARTNER G LAUSECKER B WANG K FULTON JS GABRIEL L MULLIGAN TE
Citation: Jg. Zhi et al., METABOLIC PROFILES OF MINIMALLY ABSORBED ORLISTAT IN OBESE OVERWEIGHTVOLUNTEERS/, Journal of clinical pharmacology, 36(11), 1996, pp. 1006-1011
THE INFLUENCE OF REDUCED DIETARY-FAT ABSORPTION INDUCED BY ORLISTAT ON THE PHARMACOKINETICS OF DIGOXIN IN HEALTHY-VOLUNTEERS
Authors: MELIA AT ZHI JG KOSSTWARDY SG MIN BH SMITH BL FREUNDLICH NL ARORA S PASSE SM
Citation: At. Melia et al., THE INFLUENCE OF REDUCED DIETARY-FAT ABSORPTION INDUCED BY ORLISTAT ON THE PHARMACOKINETICS OF DIGOXIN IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 35(8), 1995, pp. 840-843
INFLUENCE OF HUMAN SERUM-ALBUMIN CONTENT IN FORMULATIONS ON THE BIOEQUIVALENCY OF INTERFERON ALFA-2A GIVEN BY SUBCUTANEOUS INJECTION IN HEALTHY MALE-VOLUNTEERS
Authors: ZHI JG TELLER SB SATOH H KOSSTWARDY SG LUKE DR
Citation: Jg. Zhi et al., INFLUENCE OF HUMAN SERUM-ALBUMIN CONTENT IN FORMULATIONS ON THE BIOEQUIVALENCY OF INTERFERON ALFA-2A GIVEN BY SUBCUTANEOUS INJECTION IN HEALTHY MALE-VOLUNTEERS, Journal of clinical pharmacology, 35(3), 1995, pp. 281-284
REVIEW OF LIMITED SYSTEMIC ABSORPTION OF ORLISTAT, A LIPASE INHIBITOR, IN HEALTHY-HUMAN VOLUNTEERS
Authors: ZHI JG MELIA AT EGGERS H JOLY R PATEL IH
Citation: Jg. Zhi et al., REVIEW OF LIMITED SYSTEMIC ABSORPTION OF ORLISTAT, A LIPASE INHIBITOR, IN HEALTHY-HUMAN VOLUNTEERS, Journal of clinical pharmacology, 35(11), 1995, pp. 1103-1108
EFFECTS OF DIETARY-FAT ON DRUG ABSORPTION - COMMENTARY
Authors: ZHI JG RAKHIT A PATEL IH
Citation: Jg. Zhi et al., EFFECTS OF DIETARY-FAT ON DRUG ABSORPTION - COMMENTARY, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 487-491
THE PHARMACOKINETIC-PHARMACODYNAMIC (DIGIT-SYMBOL-SUBSTITUTION-TEST) RELATIONSHIP OF FLUMAZENIL IN A MIDAZOLAM STEADY-STATE MODEL IN HEALTHY-VOLUNTEERS
Authors: ZHI JG MASSARELLA JW MELIA AT TELLER SB SCHMITTMUSKUS J CREWS T OLDFIELD N ERB RJ LEESE PT PATEL IH
Citation: Jg. Zhi et al., THE PHARMACOKINETIC-PHARMACODYNAMIC (DIGIT-SYMBOL-SUBSTITUTION-TEST) RELATIONSHIP OF FLUMAZENIL IN A MIDAZOLAM STEADY-STATE MODEL IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 56(5), 1994, pp. 530-536
Risultati: 1-11 |